Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that
June 17, 2025
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that
Congress slashed over 57% of funding from the Congressionally Directed Medical Research Programs (CDMRP), which
Dr. Akiko Iwasaki In honor of World ME Day, we are proud to announce the
Myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), is a debilitating illness that
Dr. Carmen Scheibenbogen is the director of the Institute for Medical Immunology at Charité Hospital
Solve Together is our dynamic, patient-centered platform that aims to accelerate the discovery of treatments
The federal government is considering eliminating the CDC’s only program dedicated to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Metabolism is the set of myriad chemical reactions through which cells transform energy, and metabolites
Dr. Katharine Seton is a research fellow at the Quadram Institute in Norwich, England, a
Tell Congress to Restore Our Research! Reverse the 57% Cut to the Congressionally Directed Medical
We are proud to announce the selection of the 2025-2026 Lived Experience Taskforce (LET), a
Registration in now open for Solve M.E.’s 2025 Advocacy Week June 23-27! With a new
